McKesson U.S. Pharmaceutical president to depart
McKesson U.S. Pharmaceutical president Mark Walchirk is leaving the company to become president and chief executive officer of Patterson Companies Inc., a distributor serving the dental and animal health markets. Patterson said Tuesday that Walchirk is slated to start at the company on Nov. 20.